Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?

BACKGROUND: This study assessed the prognostic value of HE4 marker measurements at various stages of first-line chemotherapy for ovarian cancer. METHODS: The study consisted of 90 ovarian cancer patients, including 48 women undergoing primary surgical treatment and 42 patients qualified for neoadjuv...

Descripción completa

Detalles Bibliográficos
Autores principales: Chudecka-Głaz, Anita, Cymbaluk-Płoska, Aneta, Wężowska, Małgorzata, Menkiszak, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870956/
https://www.ncbi.nlm.nih.gov/pubmed/29584739
http://dx.doi.org/10.1371/journal.pone.0194270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870956/
https://www.ncbi.nlm.nih.gov/pubmed/29584739
http://dx.doi.org/10.1371/journal.pone.0194270

Ejemplares similares